Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancer

5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazolo[1,5-a]pyrimidine derivatives and related compounds as Trk kinase inhibitors for treating cancer

US Patent 11230546 · Granted Jan 25, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimid2025
5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimid2025
5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimid2025
5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimid2025
5-(2,5-difluorophenyl)pyrrolidin-1-yl)-3-(1H-pyrazol-1-yl)pyrazolo[1,5-a]pyrimid2025
Pyridazine compounds for inhibiting NLRP32025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors2025
Polo like kinase 4 inhibitors2025
Polo like kinase 4 inhibitors2025
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors2025
Inhibitors of cyclin-dependent kinase 7 (CDK7)2025